>
Spotlight October 2022: The titanium dioxide debate – why the current ECHA and EFSA hazard classification should be questioned
Due to various reports and scientific studies, titanium dioxide (TiO2)was also banned in Europe this year (2022) for use as a food additive with the indication that it could possibly be carcinogenic to humans. Although no case of tumour induction in humans has been reported since the use of this material in micro but also nano size in many products (included in paints as a white pigment for more than 80 years and permitted in foodstuffs in Europe since 2008) the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA) have concluded that the evidence would be sufficient to apply a new classification.
However, the British Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COC) and Health Canada disagree and continue to classify TiO2 as harmless because they consider the evidence from the submitted reports to be inconclusive and inapplicable.
The two here presented recent publications now comment on this new classification in Europe and come to the conclusion that this classification must be reconsidered, as there is no evidence for such a direct genotoxic effect of TiO2 in consumer products, would thus follow the British and Canadian example. The example of TiO2 makes it clear how important it is in the future to carry out toxicological tests exactly according to protocol and thus produce high-quality and comprehensible “FAIR” results (cf. Spotlights September 2022 and August 2021).
Original publications:
- Driscoll, K.E. (2022). Review of Lung Particle Overload, Rat Lung Cancer, and the Conclusions of the Edinburgh Expert Panel-It’s Time to Revisit Cancer Hazard Classifications for Titanium Dioxide and Carbon Black. Front Public Health 10, 907318
- Kirkland, D., Aardema, M.J., Battersby, R.V., Beevers, C., Burnett, K., Burzlaff, A., Czich, A., Donner, E. M., Fowler, P., Johnston, H.J., Krug, H.F., Pfuhler, S., Stankowski, L.F. (2022). A weight of evidence review of the genotoxicity of titanium dioxide (TiO₂). Regulatory Toxicology and Pharmacology, in press, journal pre-proof
Weitere Spotlights
Spotlight Juli 2020: “Nanosafety – More than just regulatory processes”
Nanosafety is more than just a compulsory aspect of nanomaterials research and regulation. This research area also has great potential to drive new innovations. It is exactly this perspective that is addressed in the special issue “Rethinking Nanosafety: Harnessing Progress and Driving Innovation” by Chen et al. 2020. The article illustrates that especially in the field of […]
Read moreSpotlight December 2020: Rethinking Nanosafety – Part II
In December we would like to draw attention to the special issue: Rethinking Nanosafety – Part II in small. In the July Spotlight we already presented Part I. This special issue “Rethinking Nanosafety – Part II” also features research papers by renowned scientists in the field of nanosafety research. The first part of this special […]
Read moreSpotlight July 2022: New definition on nanomaterials published
The European Union has published a new definition for nanomaterials as of June 2022. It is recommended that this be used as a basis for future legislation. The new documents can be found on the EC website. In the new “nanodefinition”, the essential components such as the origin or the size range of the particles […]
Read moreSpotlight February 2022: Probabilistic risk assessment – the keystone for the future of toxicology
The basics of toxicology are constantly being reconsidered, and the approach to risk assessment is therefore constantly being put to the test, because, as William Osler is cited in this publication, “Medicine (toxicology) is a science of uncertainty and an art of probability“. In this recent paper, the team around Thomas Hartung (Johns-Hopkins University/University of […]
Read more